Evidence map›Paper›PMID 30755767›Full record

ArticleGastroenterology research and practice2019

Assessing the Risk Factors for Refractory Eosinophilic Esophagitis in Children and Adults.

Erminia Ridolo, Irene Martignago, Irene Pellicelli, Cristoforo Incorvaia

Open access · goldAbstract read
In one paragraph

Article in Gastroenterology research and practice, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Eosinophilic Esophagitis-What Do We Know So Far?Journal of clinical medicine · 2023
    Review
  4. Review
  5. Review
  6. Food Allergy from Infancy Through Adulthood.The journal of allergy and clinical immunology. In practice · 2020
    Review
  7. Esophageal Dysphagia in the Elderly.Current treatment options in gastroenterology · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Erminia RidoloDepartment of Medicine and Surgery, University of Parma, Parma, Italy.ORCID 0000-0003-1439-7902
Irene MartignagoUOSD Allergology, ULSS 1 Dolomiti, S. Maria del Prato Hospital, Feltre, Italy.
Irene PellicelliDepartment of Medicine and Surgery, University of Parma, Parma, Italy.
Cristoforo IncorvaiaCardiac/Pulmonary Rehabilitation, ASST Pini/CTO, Milan, Italy.ORCID 0000-0002-3965-7988
University of Parma · ITHospital of Prato · ITIstituto Ortopedico Gaetano Pini · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundUp to one-third of the patients suffering from eosinophilic esophagitis (EoE) present a refractory form, as defined by nonresponsiveness in clinical, endoscopic, or histological assessment after first-line therapy. Several studies recently investigated which factors can influence the development of this disease, but very few analyzed the factors underlying refractory EoE.

methodsMedical charts of patients affected by EoE were retrospectively evaluated. Phenotyping of patients was conducted according to demographic, clinical, histological, and treatment variables. Then, patients were divided into responder and nonresponder to therapy and distinguished among children and adults.

resultsForty-five children and 35 adult EoE patients were included. In the pediatric population, female sex (

conclusionsOur study highlighted female sex and a higher VAS score at the time of follow-up visits as risk factors for refractory EoE in children, while the risk factors in adults were identified as fewer years of follow-up, greater diagnostic delay, use of antibiotics during infancy, and food allergy.

Identifiers

PMID30755767
PMCPMC6348890
OpenAlexW2909537189

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.